Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7205510 | 7666366 | F | 7205510-X | 20100326 | 20101228 | 20101231 | EXP | US-AMGEN-KDC439794 | AMGENSAFETY | YR | Y | 20101231 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7205510 | 1015449424 | PS | ETANERCEPT | 2 | SUBCUTANEOUS | 50 MG, 2 TIMES/WK | NOT PROVIDED | ||||
| 7205510 | 1015449425 | C | LIPITOR | 1 | ORAL | 10 MG, QD | |||||
| 7205510 | 1015449426 | C | COREG | 1 | |||||||
| 7205510 | 1015449427 | C | IRON | 2 | |||||||
| 7205510 | 1015449428 | C | POTASSIUM | 2 | |||||||
| 7205510 | 1015449429 | C | LISINOPRIL | 1 | |||||||
| 7205510 | 1015449430 | C | ATENOLOL | 1 | |||||||
| 7205510 | 1015449431 | C | FELODIPINE | 1 | |||||||
| 7205510 | 1015449432 | C | DILTIAZEM | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 7205510 | 1015449424 | PSORIASIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 7205510 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 7205510 | NEPHRECTOMY |
| 7205510 | RENAL CANCER |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 7205510 | 1015449424 | 20070119 | |||
| 7205510 | 1015449425 | 20100909 |